The possible reclassification of cannabis in the United States could expand access to credit, advertising, and ease tax burdens, opening up new opportunities for companies in the sector

Survey indicates that 3.7% of the adult population in the United States reported using subperceptual doses of psychedelics in the last year

The DEA has increased the legal quotas for the production of psychedelics such as psilocybin and DMT for 2026, focusing on scientific and medical research in the United States.

The longest strike in the US cannabis industry has ended after 45 days, with victory for Green Thumb Industries workers

With interstate cannabis commerce prohibited in the United States, many brands rely on 'grow shops' or 'illicit operators' to market their products nationwide.

MJBizDaily compiled a list of cannabis industry trends in the United States and Canada for 2022. Do these bets show some of the paths for the Brazilian scenario?

Restructuring of the CNBS and MJ ETFs brings more exposure to the emerging cannabis market in the United States

Category grows 12% annually and already represents 15.4% of the total cannabis market in the United States

The world's largest event on psychedelics will feature over 600 speakers and is expected to attract thousands of participants in June 2025 in the United States.

Companies located in Argentina, Chile, Uruguay, and the United States are facing a new type of crime: the theft of cannabis plants. Pablo Fazio discusses the risks of this new trend in his column.

Business of Cannabis: New York 2025 will bring together investors, regulators, and industry leaders to discuss the future of cannabis in the United States, focusing on innovation, sustainability, and regulation

In a press conference, the Venezuelan president states that the country will not follow the "insane trend" of legalizing drugs and points to the production of "synthetic superweed" in the United States.

Despite the executive order signed by Donald Trump, cannabis continues without federal legalization in the US, keeping the market dependent on state laws

Statement contradicts Trump's previous support for cannabis reform

The states of Arizona, Maryland, Ohio, and Pennsylvania will benefit from the new quality of cannabis, named "Tyson 2.0"

Organization states funding initiatives aiming to extinguish the adult-use market in both U.S. states

With the approval of the MilCon-VA amendment, over 9 million veterans may benefit in states where its use is legal

The analysis, published by the Journal of the American Medical Association, examined federal data from the Youth Risk Behavior Survey between 1993 and 2019, in 10 U.S. states, comparing both medical and adult use.

While the US seeks to include medicinal cannabis in insurance coverage, Brazil advances through state laws and judicial decisions for access to treatment

The search for relief from chronic pain and sleep disorders reveals a cultural and therapeutic shift among the elderly